Deep Relaxation Using Virtual Reality Intervention Before Surgery for Healthcare Professionals Working in the Operating Room
DEEP_VR
1 other identifier
interventional
80
2 countries
2
Brief Summary
The goal of this clinical trials is to primary learn if deep relaxation using Virtual Reality (VR) compared to a low stimulus environment can lower perceived and measured stress in healthcare professionals working in the operating room. We aim to determine:
- whether the use of a low-stimulus environment significantly lowers the stress response in OR health care workers just before entering the OR;
- whether the use of a responsive VR system environment significantly lowers the stress response in OR health care workers just before entering the OR;
- Whether the use of a responsive VR environment is both an effective and cost-effective solution compared to the low-stimulus environment, in terms of significantly mitigating stress in OR team members as measured by their biometrics, just before they enter the OR to do their job. Hypothesis
- The use of a 10-minute real-time adaptive VR intervention or a low-stimulus environment intervention administered at least 15 minutes before entering the operating room (OR), significantly reduces stress in OR staff, as measured by a within-person reduction in heart rate of at least 10 beats per minute (BPM) over the 10-minute intervention period
- The reduction in heart rate over a 10-minute intervention period is significantly greater for the real-time adaptive VR intervention compared to the low-stimulus environment intervention, with an expected mean difference (delta) of 5 BPM, indicating superior stress-reducing effects of the VR intervention.
- The use of a real-time adaptive VR intervention and the use of a low stimulus environment intervention of 10 minutes at least 15 minutes before entering the OR significantly reduces perceived stress for OR staff, as measured by Numeric Rating Scale (NRS) stress scores within person.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2025
CompletedFirst Posted
Study publicly available on registry
March 13, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
March 13, 2026
February 1, 2026
1 month
August 19, 2025
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Perceived Stress level
NRS score ranging from 0 (not stessed) to 10 (very stressed)
- immediately before each intervention (pre-intervention) - immediately after each intervention (post-intervention)
Non invasive biomarkers
Non invasive biomarkers eg heart rate and heart rate variability measured with a polarOH1 armband
immediately before each intervention (pre-intervention) for 5 minutes, during the intervention 10 minutes and immediately after each intervention 1 minute (post-intervention)
Secondary Outcomes (2)
User satisfaction
Immediately after completion of the last intervention of the study (post intervention after the third intervention)
Cost-effectiveness analysis (CEA) of the intervention. up to 50 weeks after the last participant has completed all interventions
through study completion, an average of 1 year
Other Outcomes (5)
Burnout
Baseline
Burnout
Baseline
Resilience
Baseline
- +2 more other outcomes
Study Arms (3)
AAB
EXPERIMENTALVR - VR - low stimulus environment
ABA
EXPERIMENTALVR - low stimulus environment - VR
BAA
EXPERIMENTALLow stimulus environment - VR - VR
Interventions
Participants will receive a VR headset, in which the participant can choose from a number of VR images and sceneries of the HealthyMind® (HM) VR simulation to relax. The software is able to adapt to user's HR and HRV, and developed by Partner HealthyMind (HM). HRV is chosen as prime parameter for biofeedback steering of scenery, as it is highly indicative and considered reliable in measuring a person's stress level. (27-30) Before starting the experience, participants select a VR scenery based on their personal preference. Allowing participants to choose their own VR scenery minimizes the risk of exposing them to an environment that could be stress-inducing rather than stress-reducing.(31, 32) HR and HRV will be measured in real time during the intervention using the POLAR OH1 armband built and registered for the purpose. We chose the POLAR OH1 band because of its accurate HRV measurements, its ability to connect with the VR device, and its user-friendliness. In respo
Participants will be brought into an induced low-sensory, low-stimulus environment. This entails wearing the VR headset with a dark-only display, and no sound on headphones. This, to facilitate a calm environment without distractions. Before the start of the intervention, the VR headset will display a short visual and audio message confirming that the participant is in a low-stimulus environment and that the system is functioning properly.
Eligibility Criteria
You may qualify if:
- Volunteering and consented healthcare professionals ( ≥ 18 years) working in the operating room
- Circulatory-, scrub-, and anesthesia nurses, anesthesiologists, surgical specialists, residents, medical students, or persons in training for the above mentioned.
You may not qualify if:
- history of epilepsy.
- claustrophobia or nyctophobia.
- experienced VR scenery via a headset including headphones a trigger for headache, migraine, dizziness, drowsiness, nausea or other physical or mental discomfort.
- vestibular nystagmus, otosclerosis, ear infections,
- impaired hearing or deafness of either ear.
- glaucoma, active eye infections or damage to orbital, cornea or lens.
- diagnosed with chronic insomnia .
- latex allergy as VR goggles may contain latex in the lens surround.
- arrythmia, bradycardia or tachycardia, or those using cardiac medication against dysrhythmias.
- All medication that may potentially induce dysrhythmias or of influence on blood pressure levels.
- not able to wear a VR headset and/or noise canceling headphones for any other reason as indicated by themselves.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amsterdam UMC, location VUmclead
- Universitätsklinikum Hamburg-Eppendorfcollaborator
- Rigshospitalet, Denmarkcollaborator
Study Sites (2)
Rhigshospitalet
Copenhagen, Denmark
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marlies p Schijven, Prof. dr.
AmsterdamUMC
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, drs.
Study Record Dates
First Submitted
August 19, 2025
First Posted
March 13, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
March 13, 2026
Record last verified: 2026-02